News

BMJ1d
Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies
Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University, Prague, Czech Republic O Kryštůfková, Institute of Rheumatology, Prague, Czech Republic, Na Slupi 4, 120 00 ...
BMJ1d
The International Classification of Functioning, Disability and Health (ICF) Core Sets for rheumatoid arthritis: a way to specify functioning
1 Department of Physical Medicine and Rehabilitation, Ludwig-Maximilians-University, Munich, Germany 2 ICF Research Branch of the WHO FIC CC (DIMDI), IMBK—Department of Physical Medicine and ...
BMJ1d
Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus
2 Department of Internal Medicine, General Hospital of Kufstein, Kufstein, Austria 3 Department of Internal Medicine I, Innsbruck Medical University, Innsbruck, Austria 4 Department of Internal ...
BMJ2d
Digital ulcers predict a worse disease course in patients with systemic sclerosis
2 Amsterdam Rheumatology Center/University of Amsterdam & Atrium Medical Center, Heerlen, The Netherlands 3 Leiden University Medical Center, Leiden, The Netherlands 15 Division of Rheumatology AOUC & ...
BMJ2d
Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial
Objectives Risankizumab is an interleukin-23 inhibitor under study for the treatment of patients with psoriatic arthritis (PsA). The phase 3 KEEPsAKE 2 trial investigated the efficacy and safety of ...
BMJ3d
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis
Objectives Short-term predictive endpoints of chronic kidney disease (CKD) are needed in lupus nephritis (LN). We tested response to therapy at 1 year. Results We studied 381 patients (90.5% ...
BMJ4d
Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis
Background Studies examining the relationship between serological status (rheumatoid factor and/or anticitrullinated antibody) and rituximab treatment outcome in rheumatoid arthritis (RA) have been ...
BMJ5d
Predictive factors of work disability in rheumatoid arthritis: a systematic literature review
1 Coronel Institute for Occupational and Environmental Health, Academic Medical Centre, Research Institute Amsterdam Centre for Health and Health Care Research (AmCOGG), Amsterdam, The Netherlands 2 ...
BMJ5d
Long-term measurement of anti-adalimumab using pH-shift-anti-idiotype antigen binding test shows predictive value and transient antibody formation
1 Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, Amsterdam, The Netherlands 2 Department of Rheumatology, Jan van Breemen Research Institute/Reade, ...
BMJ5d
Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial
Objectives To compare over 2 years the safety, efficacy and radiographic outcomes of subcutaneous abatacept versus adalimumab, in combination with methotrexate (MTX), in patients with rheumatoid ...
BMJ5d
Inequities in access to biologic and synthetic DMARDs across 46 European countries
1 Department of Health Promotion and Education, Maastricht University, School for Public Health and Primary Care (CAPHRI), Maastricht, The Netherlands 2 Department of Rheumatology, Hospital Garcia de ...
BMJ5d
Interpreting radiographic data in rheumatoid arthritis
Plain film radiography is the preferred method for evaluating disease progression in rheumatoid arthritis and for establishing the efficacy of new disease modifying antirheumatic agents. However, the ...